Under construction – not a live service
Sign in

Chronic kidney disease: open trials in China

120 open trials have a site in China. Registry data; only the trial team decides who can take part.

  • NCT06742723

    A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

    Trial Treatment · Phase 3 · AstraZeneca

    Baotou · Beijing · Changchun · Changsha · Changzhou · Chengdu · Chongqing · Dongwan · Fuyang · Guangzhou · Haikou · Hefei · Hengyang · Heze · Huaian · Jiaxing · Jilin City · Jinan · Jinhua · Jining · Lanzhou · Linhai · Linyi · Luoyang · Nanchang · Nanning · Ningbo · Panjin · Pingxiang · Shanghai · Shantou · Shenyang · Shenzhen · Suzhou · Taian · Tianjin · Wanzhou · Wuhan · Wuxi · Xi'an · Xianyang · Yantai · Yinchuan · Zhengzhou · Zhongshan · Zhuzhou · Zigong

    Registry updated 2026-11-06

  • NCT07122401

    Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism

    Trial Treatment · Phase 3 · Shaanxi Micot Pharmaceutical Technology Co., Ltd.

    Zhongshan Hospital, Shanghai

    Registry updated 2026-11-05

  • NCT07241390

    A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Peking University People's Hospital, Beijing · Beijing Pinggu District Hospital, Beijing · Peking University Third Hospital, Beijing · China-Japan Union Hospital, Changchun · Changde First People's Hospital, Changde · Changzhou Second People's Hospital, Changzhou · Sichuan Provincial People's Hospital, Chengdu · 2nd Affiliated Hospital Chongqing Medical University, Chongqing · Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian · Guangdong Provincial People's Hospital, Guangzhou · Zhujiang Hospital, Guangzhou · Zhejiang Provincial People's Hospital, Hangzhou · The First Hospital of Harbin Medical University, Harbin · Jinan Central Hospital, Jinan · Jingjiang People's Hospital, Jingjiang · Jingzhou Central Hospital, Jingzhou · Lishui Central Hospital, Lishui · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · The Second Affiliated Hospital of Nanchang University, Nanchang · Nanjing First Hospital, Nanjing · Zhongshan Hospital,Fudan University, Shanghai · Jiading District Central Hospital, Shanghai · The Second Affiliated Hospital Of Shantou University Medical College, Shantou · The Second Affiliated Hospital of Soochow University, Suzhou · Renmin Hospital of Wuhan University, Wuhan · Shaanxi provincial people's hospital, Xi'an · The Affiliated Hospital of Xuzhou Medical College, Xuzhou · Zigong First People's Hospital, Zigong

    Registry updated 2026-11-04

  • NCT07134335

    UBT251 Injection Phase II Clinical Study (CKD)

    Trial Treatment · Phase 2 · The United Bio-Technology (Hengqin) Co., Ltd.

    Peking University First Hospital, Beijing

    Registry updated 2026-11-03

  • NCT07323095

    Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia

    Trial Treatment · Phase 2 · Atom Therapeutics Co., Ltd

    Xuanwu Hospital, Capital Medical University, Beijing · Beijing Tsinghua Changgung Hospital, Beijing · Peking University First Hospital, Beijing · Zhejiang Provincial People's Hospital, Hangzhou · Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine, Hangzhou · Jiangsu Province Hospital, Nanjing · Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

    Registry updated 2026-11-02

  • NCT07900438

    A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China

    Trial Treatment · Phase 4 · Novo Nordisk A/S

    The People's Hospital of Anyang City/ TGE Center Hospital of Anyang City-Nephrology, Anyang · The First Affiliated Hospital of Baotou Medical College-Nephrology, Baotou · Peking University First Hospital-Nephrology, Beijing · Beijing Friendship Hospital, Capital Medical University-Nephrology, Beijing · Beijing Anzhen Hospital, Capital Medical University-Nephrology, Beijing · The Second Norman Bethune Hospital of Jilin University-Nephrology, Changchun · Changzhou No.2 People's Hospital-Nephrology, Changzhou · Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Affiliated Hospital of UESTC-Nephrology, Chengdu · Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital) -Nephrology, Dalian · Fu Yang People's Hospital-Nephrology, Fuyang · Huizhou Central People's Hospital-Endocrinology, Huizhou · Jinan Central Hospital-General Medicine, Jinan · The Second Hospital & Clinical Medical School, Lanzhou University-Nephrology, Lanzhou · Taizhou Hospital of Zhejiang Province-Nephrology, Linhai · The Second Affiliated Hospital of Nanjing Medical University-Endocrinology, Nanjing · Ningbo No. 2 Hospital-Nephrology, Ningbo · Panjin Liaoyou Gemflower Hospital-Nephrology, Panjin · Pingxiang People's Hospital-Endocrinology, Pingxiang · Shanghai General Hospital-Nephrology, Shanghai · The Second Affiliated Hospital of Shantou University Medical College-Nephrology, Shantou · The Second Hospital of Hebei Medical University-Nephrology, Shijiazhuang · Siping City Central People's Hospital-Nephrology, Siping · Qinghai Provincial People's Hospital-Endocrinology, Xining · The Second People's Hospital of Yibin-Department of Nephrology, Yibin · Yichang Central People's Hospital-Nephrology, Yichang · The Affiliated Hospital of Jiangsu University-Endocrinology, Zhenjiang

    Registry updated 2026-10-28

  • NCT06593392

    Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

    Trial Treatment · Phase 2 · Vifor Fresenius Medical Care Renal Pharma

    Sichuan University West China Second University Hospital, Chengdu · Guangzhou Women and Children's medical center, Guangzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The Children's Hospital, Zhejiang University School of Medicine, Hangzhou · The Children's Hospital of Fudan University, Shanghai · Huazhong University of Science and Technology-Tongji Medical College-The Central Hospital of Wuhan, Wuhan · Xi'an Children's Hospital, Xi'an

    Registry updated 2026-10-23

  • NCT07245186

    Strategies for Proactive Health in People With Kidney Function Decline

    Research · Huashan Hospital

    Huashan Hospital, Fudan University, Shanghai

    Registry updated 2026-10-22

  • NCT07888855

    Registry updated 2026-10-22

  • NCT07877103

    Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients

    Trial Treatment · Phase 4 · The First Affiliated Hospital of Guangzhou Medical University

    The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

    Registry updated 2026-10-16

  • NCT06715735

    HAPA-based Intervention in Adults With Metabolic Syndrome and Chronic Kidney Disease

    Trial Treatment · Chinese University of Hong Kong

    West China Hospital of Sichuan University, Chengdu

    Registry updated 2026-10-09

  • NCT04557462

    A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

    Trial Treatment · Phase 3 · Novartis Pharmaceuticals

    Beijing · Changchun · Changsha · Guangzhou · Luoyang · Ningbo · Qingdao · Shanghai · Shenzhen · Taiyuan · Ürümqi · Wenzhou · Xian · Yinchuan · Zhengzhou

    Registry updated 2026-10-05

  • NCT07848880

    A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney Disease

    Trial Treatment · Phase 2 · Zhejiang Doer Biologics Co., Ltd.

    Peking University Third Hospital, Beijing · Peking University First Hospital, Beijing

    Registry updated 2026-09-30

  • NCT07624305

    A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

    Trial Treatment · Phase 3 · AstraZeneca

    Baotou · Beijing · Changchun · Changsha · Changzhou · Chengdu · Chongqing · Dongguan · Dongyang · Ganzhou · Guangzhou · Guiyang · Hebei · Hohhot · Huaian · Jinan · Jining · Jiujiang · Linhai · Nanchang · Nanjing · Nanning · Ningbo · Panjin · Pingxiang · Qingzhou · Shanghai · Shantou · Shenyang · Shenzhen · Suzhou · Ürümqi · Wuhan · Wuxi · Xiamen · Xuzhou · Yancheng · Yangzhou · Yantai · Yibin · Yinchuan · Zhenjiang · Zhuzhou

    Registry updated 2026-09-24

  • NCT07645794

    Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FF

    Research · Capital Medical University

    Nephrology Department of Beijing Jishuitan Hospital, Beijing

    Registry updated 2026-09-23

  • NCT05485961

    Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

    Trial Treatment · Phase 2/3 · CSL Behring

    Inner Mongolia Baotou City Central Hospital (Baotou Central Hospital), Baotou Shi · Peking University People's Hospital, Beijeing · Beijing Tsinghua Chang Gung Hospital, Beijing · Peking University Third Hospital, Beijing · Peking University First Hospital, Beijing · China Rehabilitation Research Center (Beijing Boai Hospital), Beijing · Beijing Miyun Hospital, Beijing · Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (SAMSPH), Chengdu · The Affiliated Zhongshan Hospital (Dalian Railroad Hospital), Dalian · People's Hospital of Deyang, Deyang Shi · Dongguan People's Hospital, Dongguan · The First People's Hospital - Foshan, Foshan Shi · The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou · Anhui Medical University - The Second Hospital, Hefei · The First Hospital Of Jiaxing, Jiaxing · Gansu Provincial People's Hospital, Lanzhou · Jiangsu Province Hospital /The First Affiliated Hospital with Nanjing Medical University, Lanzhou · Henan University of Science and Technology-The First Affiliated Hospital, Luoyang Shi · The Third Hospital of Mianyang, Mianyang · Nanchang University - The First Affiliated Hospital, Nanchang · Jiangsu Province Hospital of Chinese Medicine, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · The People's Hospital Guangxi Zhuang of Autonomous Region, Nanning · Southern Medical University - Jiangxi Pingxiang People's Hospital, Pingxiang · Shanghai Jiao Tong University School of Medicine (SJTUSM)-Renji Hospital, Shanghai · Shanghai First People's Hospital, Shanghai Shi · Shenzhen Second People's Hospital (Shenzhen University First Affiliated Hospital), Shenzhen · The Fourth Hospital of Hebei Medical University, Shijiazhuang · Shijiazhuang People's Hospital, Shijiazhuang · Second hospital of Shanxi Medical University, Taiyuan · Tianjin People's Hospital, Tianjin · Huazhong University of Science and Technology - Tongji Medical College - The Central Hospital of Wuhan (Wuhan Second Hospital), Wuhan · Renmin Hospital of Wuhan University/Hubei General Hospital, Wuhan · Wuxi People's Hospital, Wuxi · Zhongshan Hospital Xiamen University, Xiamen · Yan'an University Xianyang Hospital, Xianyang · Xinxiang City First People's Hospital, Xinxiang · Northern Jiangsu People's Hospital, Yangzhou · Yibin Second People's Hospital, Yibin · The First Affiliated Hospital of Zhengzhou University, Zhengzhou · Affiliated Hospital of Jiangsu University, Zhenjiang

    Registry updated 2026-09-21

  • NCT07822152

    Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy

    Trial Treatment · Phase 1 · Tongji Hospital

    Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, WUHAN, HUBEI, Wuhan

    Registry updated 2026-09-16

  • NCT07098351

    Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

    Trial Treatment · Guangdong Provincial People's Hospital

    Guangdong Provincial People's Hospital, Guangzhou

    Registry updated 2026-09-14

  • NCT07753993

    A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

    Trial Treatment · Phase 3 · AstraZeneca

    Baoding · Beijing · Changchun · Changsha · Changzhou · Chengdu · Chenzhou · Chongqing · Dongguan · Foshan · Ganzhou · Guangzhou · Guiyang · Hefei · Huangshi · Huizhou · Jiangmen · Jining · Linfen · Luoyang · Nanchang · Nanjing · Nanning · Ningbo · Panjin · Pingxiang · Qingzhou · Sacramento · Shanghai · Shantou · Shenzhen · Shijiazhuang · Tianjin · Ürümqi · Wuhan · Wuxi · Xi'an · Xuzhou · Yancheng · Yangzhou · Yantai · Yibin · Zhenjiang · Zhongshan · Zigong · Zunyi

    Registry updated 2026-09-09

  • NCT06946394

    Use of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI

    Trial Treatment · Phase 4 · The First Affiliated Hospital of Dalian Medical University

    Poster, Dalian

    Registry updated 2026-09-02

  • NCT07662135

    A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

    Trial Treatment · Phase 3 · AstraZeneca

    Binzhou · Changsha · Chengdu · Hangzhou · Jinan · Liaocheng · Liuzhou · Luoyang · Nanjing · Nanyang · Suining Shi · Yibin · Yichang · Zhengzhou

    Registry updated 2026-09-02

  • NCT06712654

    A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

    Trial Treatment · Phase 2 · R1 Therapeutics

    Peking University People's Hospital, Beijing · Peking University First Hospital, Beijing · Sichuan Provincial People's Hospital, Chengdu · Zhongda Hospital Southeast University, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai · Zhengzhou University - First Affiliated Hospital, Zhengzhou

    Registry updated 2026-08-26

  • NCT07781124

    Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities

    Research · Vantive Health LLC

    The First Affiliated Hospital of Baotou Medical College, Baotou · Beijing Haidian Hospital, Beijing · Peking University Third Hospital, Beijing · Peking University First Hospital, Beijing · China-Japan Friendship Hospital, Beijing · The Second Norman Bethune Hospital of Jilin University, Changchun · The Third Xiangya Hospital of Central South University, Changsha · The Second Affiliated Hospital of Chongqing Medical University, Chongqing · Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou · Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou · The Second Affiliated Hospital of Harbin Medical University, Harbin · The Affiliated Hospital of Qingdao University, Qingdao · Shanghai Sixth People's Hospital, Shanghai · Hebei medical university third hospital, Shijiazhuang · Tianjin First Central Hospital, Tianjin · Zhongnan Hospital of Wuhan University, Wuhan · Wuxi People's Hospital, Wuxi · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · Yantai Yuhuangding Hospital, Yantai · Henan Provincial People's Hospital, Zhengzhou

    Registry updated 2026-08-24

  • NCT07775846

    QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy

    Trial Treatment · Phase 4 · Huijie Zhang

    Zhongshan Hospital,Fudan University, Shanghai

    Registry updated 2026-08-20

  • NCT07773051

    LineMatrix® Biological Vascular Graft for the Creation of Arteriovenous Graft

    Trial Treatment · Longhua Hospital

    Beijing Haidian Hospital, Beijing · The First Affiliated Hospital of Chongqing Medical University, Chongqing · The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of NanChang University, Nanchang · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · LongHua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai · South China Hospital of Shenzhen University, Shenzhen · The First Hospital of Hebei Medical University, Shijiazhuang · Tongji Hospital Affiliated to Tongji Medical Collage of Huazhong University of Science and Technology, Wuhan · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · The First Affiliated Hospital of Zhengzhou University, Zhengzhou

    Registry updated 2026-08-19

All Chronic kidney disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Under construction, not live – Chronic kidney disease trials in China – Frontlight Research